case_images: PMC11835130_01
case_images: Chest high-resolution computed tomography on July 7, 2024 showed a few ground glass shadows in both lungs.
case_images: medi-104-e41408-g001.jpg
case_images: PMC11835130_01_medi-104-e41408-g001.jpg
case_images: F1
case_images: In conjunction with the patient's chest high-resolution computed tomography findings (Fig. 1), this suggests a diagnosis of RPILD with anti-MDA5ab+.
case_images: The timeline summarizes the successive treatments administered to the patient after diagnosis of rapidly progressive interstitial lung disease. Anti-MDA5ab+ = antimelanoma differentiation-associated gene 5 antibody positive, ECMO = extracorporeal membrane oxygenation.
case_images: medi-104-e41408-g002.jpg
case_images: PMC11835130_01_medi-104-e41408-g002.jpg
case_images: F2
case_images: On July 23, 2024, adequate oxygenation was not achieved (PaO2/FiO2 ratio < 75) despite maximal ventilatory support, leading us to start v-v ECMO (right femoral/ right jugular veins) as a bridge to lung transplantation (Fig. 2).